Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 1, 2006Endocrine Related Cancer

Growth factor receptor interplay and resistance in cancer

View Full Paper
Ask AI
Bookmark
Share

Authors

HJHelen E. JonesUniversity of EdinburghJGJulia M.W. GeeAlberta Health ServicesIHIain R. HutchesonCardiff University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Jones et al. (2006) studied this question.

synapsesocial.com/papers/6a75b6c3dcfefe9676dd8ef3https://doi.org/10.1677/erc.1.01275
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Insulin-Like Growth Factor-I Receptor Signaling and Resistance to Trastuzumab (Herceptin)2001 · 895 citations
  2. 2The Type 1 growth factor receptors and their ligands considered as a complex system.2001 · 81 citations
  3. 3Phase II Trial of Cetuximab in Patients With Refractory Colorectal Cancer That Expresses the Epidermal Growth Factor Receptor2004 · 1,705 citations
  4. 4Insulin-like growth factor-I receptor signalling and acquired resistance to gefitinib (ZD1839; Iressa) in human breast and prostate cancer cells2004 · 298 citations
  5. 5Nonendocrine Pathways and Endocrine Resistance2004 · 118 citations